Is this actionable now?

unknown. Periodic BIRAC calls and two-phase review; no permanent cash window.

A qualifying Indian biotech startup or SME must propose innovative in-house or collaborative R&D and provide call-specific contribution and facilities.

What burden and restrictions apply?

Milestone releases require technical reports, statements of expenditure, utilisation certificates and audits; soft-loan terms apply where used. Approved biotechnology R&D only; later-stage or non-R&D cost must fit the selected phase.

What evidence exists?

SBIRI provides a staged route for small Indian biotechnology businesses to move innovative R&D toward commercialization. No comparable current application denominator, award count and acceptance rate are published.

BIRAC Small Business Innovation Research Initiative

Phase- and project-specific grant plus possible soft-loan support for Indian biotechnology SMEs; current call controls ceilings · Biotechnology Industry Research Assistance Council

BIRAC Small Business Innovation Research Initiative is a grant programme from Biotechnology Industry Research Assistance Council for Indian biotechnology startups and SMEs meeting BIRAC ownership, incorporation, and R&D criteria Current lifecycle: unknown. Real economics: Phase- and project-specific grant plus possible soft-loan support for Indian biotechnology SMEs; current call controls ceilings.

Tier 3governmentindiabiotechgrant

Apply Official site Open in the live directory

Key facts

Funder	Biotechnology Industry Research Assistance Council
Amount	Phase- and project-specific grant plus possible soft-loan support for Indian biotechnology SMEs; current call controls ceilings
Decision time	No universal application-to-decision interval is published for the currently verified route.
Eligibility	A qualifying Indian biotech startup or SME must propose innovative in-house or collaborative R&D and provide call-specific contribution and facilities.
Restrictions	Milestone releases require technical reports, statements of expenditure, utilisation certificates and audits; soft-loan terms apply where used. Approved biotechnology R&D only; later-stage or non-R&D cost must fit the selected phase.
Status	unknown

Always confirm on the official page before applying — dates and terms change.

Application process

Submit to a live SBIRI call
Pass eligibility and scientific review
Present to expert committee
Negotiate phased grant/loan milestones
Report eligible cost and technical progress

Background

Biotechnology Industry Research Assistance Council operates BIRAC Small Business Innovation Research Initiative. This pass separates direct cash, repayable finance, credits, incentives and umbrella programs so later ranking does not compare unlike instruments. SBIRI provides a staged route for small Indian biotechnology businesses to move innovative R&D toward commercialization.

How the application really works

Submit to a live SBIRI call → Pass eligibility and scientific review → Present to expert committee → Negotiate phased grant/loan milestones → Report eligible cost and technical progress

Tips

Show direct fit with biotechnology.

Watch out for

Current lifecycle is unknown.
Milestone releases require technical reports, statements of expenditure, utilisation certificates and audits; soft-loan terms apply where used.
Approved biotechnology R&D only; later-stage or non-R&D cost must fit the selected phase.

Track record

SBIRI provides a staged route for small Indian biotechnology businesses to move innovative R&D toward commercialization.

No comparable current application denominator, award count and acceptance rate are published.

Frequently asked questions

Is this actionable now?: unknown. Periodic BIRAC calls and two-phase review; no permanent cash window.
What is the real economic value?: Phase- and project-specific grant plus possible soft-loan support for Indian biotechnology SMEs; current call controls ceilings
Who is eligible?: A qualifying Indian biotech startup or SME must propose innovative in-house or collaborative R&D and provide call-specific contribution and facilities.
How does selection work?: Submit to a live SBIRI call; Pass eligibility and scientific review; Present to expert committee; Negotiate phased grant/loan milestones; Report eligible cost and technical progress. No universal application-to-decision interval is published for the currently verified route.
What burden and restrictions apply?: Milestone releases require technical reports, statements of expenditure, utilisation certificates and audits; soft-loan terms apply where used. Approved biotechnology R&D only; later-stage or non-R&D cost must fit the selected phase.
What evidence exists?: SBIRI provides a staged route for small Indian biotechnology businesses to move innovative R&D toward commercialization. No comparable current application denominator, award count and acceptance rate are published.

Sources

birac.nic.in/sbiri.php — Official applicant, phased support and application route (checked 2026-08-10)